To amend title XVIII of the Social Security Act to permit direct payment to pharmacies for certain compounded drugs that are prepared by the pharmacies for a specific beneficiary for use through an implanted infusion pump.

Bill: 113-hr-232
Sponsor: full_name: Rep. Harper, Gregg [R-MS-3]
Introduced: 2013-01-14
Policy area: Health
Subjects: Drug therapy

Health technology, devices, supplies

Medicare

Prescription drugs
Latest action: action_date: 2013-01-28
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2013-01-14
action_desc: Introduced in House
text: <p>Amends title XVIII (Medicare) of the Social Security Act to authorize direct payment under part B (Supplementary Medical Insurance Benefits for the Aged and Disabled) to a pharmacy for certain covered compound drugs prepared by the pharmacy for a specific beneficiary for the effective use of an implanted infusion pump.</p>

tv_txt: I 113th CONGRESS 1st Session H. R. 232 IN THE HOUSE OF REPRESENTATIVES January 14, 2013 Mr. Harper introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend title XVIII of the Social Security Act to permit direct payment to pharmacies for certain compounded drugs that are prepared by the pharmacies for a specific beneficiary for use through an implanted infusion pump.

1. Medicare direct payment to pharmacies for certain compounded drugs that are prepared by the pharmacies for a specific beneficiary for use through an implanted infusion pump (a) In general The first sentence of section 1842(b)(6) of the Social Security Act ( 42 U.S.C. 1395u(b)(6) ) is amended— (1) by striking and before (H) ; and (2) by inserting before the period at the end the following: , and (I) in the case of covered compounded drugs that are prepared by a pharmacy for a specific individual, are dispensed, directly or indirectly, to the individual, are necessary for the effective use of, or therapeutic benefit from, an implanted infusion pump (regardless of who refills the pump), and are billed directly by the pharmacy, payment shall be made to the pharmacy . (b) Effective date The amendments made by subsection (a) shall apply to drugs dispensed on or after January 1, 2013.